ReviewPharmaceutics2023

Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease.

Federico Bernardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.